pe
pep-05123 v1 CC-BY-SA-4.0

CCK blood-sugar & appetite peptide

Lab-stage peptide designed to switch on the body's natural blood-sugar and appetite control system; not an approved medicine.

statuscomputed targetGLP-1R length33 aa refs2
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.832
pTM0.804
avg pLDDT69.7
ranking score0.724
STRUCTURE · PEP-05123 × GLP-1R
ranking0.724
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence33 aa
15101520253033
KAPSGRMSIVK NLQNLDPSHRI SDRDYMGWMDF
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.8324079513549805 boltz-2
ranking score 0.7242377996444702 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.944global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Ile-Val-Lys-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). CCK blood-sugar & appetite peptide (pep-05123, v1). PeptideModel. https://peptidemodel.com/card/pep-05123
@peptide{pep05123,
  sequence = {KAPSGRMSIVKNLQNLDPSHRISDRDYMGWMDF},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use